Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market

Industry insiders often have perspectives that are invaluable for investors to learn. In that vein, AstraZeneca's (NASDAQ: AZN) CEO, Pascal Soriot, recently made some interesting remarks during the company's second-quarter earnings call with analysts. https://www.nasdaq.com/articles/heres-what-astrazenecas-ceo-has-say-about-weight-loss-drugs-market